MVM Partners, a life science investment fund, led a $62m funding round in SkyCell, provider of temperature-controlled container solutions. Additional investors include Swiss Entrepreneurs Fund and BCGE Bank-backed Capital Transmission. "Covid-19 is a strong accelerator for the adoption of SkyCell’s innovative hybrid containers. Pharma companies need to ensure a direct product release – without temperature excursions – which is supported by our IoT monitoring system. To further support this growth, SkyCell has decided to raise capital to achieve one of the most solid financial backing in our industry. This capital injection is greater than the corporate value of some of our competitors and demonstrates SkyCell’s value to the global healthcare system," Richard Ettl, SkyCell CEO.